Ambalal Sarabhai Enterprises Limited Stock Price Today (NSE: AMBALALSA)

Ambalal Sarabhai Enterprises Limited

39.82+1.23 (+3.19%)
Market Closed

Fundamental Score

...

Ambalal Sarabhai Enterprises Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Ambalal Sarabhai Enterprises Limited share price today is 39.82, up +3.19% on NSE/BSE as of 16 September 2026. Ambalal Sarabhai Enterprises Limited (AMBALALSA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 237.80 (Cr). The 52-week high for AMBALALSA share price is 49.90 and the 52-week low is 37.15. At a P/E ratio of 12.88x, AMBALALSA is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 12.38% and a debt-to-equity ratio of 0.36.

Ambalal Sarabhai Enterprises Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
49.90
Low
39.82
Volume
1.1L
Change
-12.23%

Ambalal Sarabhai Enterprises Limited share price chart: -12.23% return over the past month. 52-week high ₹49.90, 52-week low ₹37.15.

Ambalal Sarabhai Enterprises Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
38.4540.0037.1539.8241.42K (Cr)
40.5040.9838.3238.5945.06K (Cr)
41.1041.7939.6840.3356.92K (Cr)
42.0042.5041.1041.5429.62K (Cr)
40.6242.7940.6242.4320.45K (Cr)
42.2543.1041.5042.0538.63K (Cr)
42.5244.7542.5242.9823.82K (Cr)
43.6745.6042.8043.7339.96K (Cr)
44.9445.5043.5143.6724.30K (Cr)
42.2544.5042.2544.1044.13K (Cr)

Ambalal Sarabhai Enterprises Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
46.0046.2037.1539.82-13.43%
33.0149.9033.0145.62+38.20%
32.9836.4830.0034.87+5.73%
34.4038.8531.0032.39-5.84%
31.0436.5830.0035.69+14.98%
25.1336.0024.0531.80+26.54%
25.0129.2523.9024.27-2.96%
28.8929.8525.0626.24-9.17%
28.5929.4423.1227.58-3.53%
28.4233.0025.9728.58+0.56%
33.4033.4028.2628.40-14.97%
32.6438.5031.5032.55-0.28%

Returns & Performance

Poor

Return on Equity (ROE)

12.38%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.69%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

6.48%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Ambalal Sarabhai Enterprises Limited Valuation Check

Excellent

Price to Earnings (P/E)

12.88x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

31.36%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

13.44%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

1.05%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

4.35%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

9.51%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

9.51%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Good

Debt to Equity Ratio

0.36x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

5.33x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-4.76 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Ambalal Sarabhai Enterprises Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AMBALALSA across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Attractive Valuation (P/E: 12.88 vs Industry: 34.89)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Interest Coverage (5.33x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Limited Growth History (4.35% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Liquidity Concerns (Current Ratio: 0.98)

Observation: Current assets may not adequately cover short-term liabilities.

Analysis: Current ratio <1.0 raises working capital concerns.

Negative Free Cash Flow (₹-4.76 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Ambalal Sarabhai Enterprises Limited vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Ambalal Sarabhai Enterprises Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
29.1/100
40
₹237.80
12.9
Average
12.38%
Average
11.69%
Average
0.4
Excellent
9.51%
Good
4.35%
Average
0.00%
66.4/100
1865
₹447445.46
37.0
Average
14.74%
Average
19.31%
Good
0.0
Excellent
31.64%
Excellent
11.78%
Good
0.82%
56.3/100
9488
₹251432.00
86.1
Average
16.19%
Good
20.38%
Excellent
0.0
Excellent
5.29%
Good
8.67%
Good
0.41%
51.4/100
4930
₹166860.78
78.8
Average
27.07%
Excellent
14.09%
Average
1.8
Average
11.56%
Good
11.80%
Good
0.76%
74.1/100
1127
₹112514.52
25.1
Average
19.74%
Good
21.77%
Excellent
0.4
Excellent
18.76%
Excellent
12.45%
Good
0.09%
40.2/100
1363
₹110118.03
32.7
Average
11.82%
Average
15.67%
Good
0.0
Excellent
10.03%
Good
8.01%
Good
0.90%
34.1/100
1937
₹104646.43
95.6
Average
18.19%
Good
21.35%
Excellent
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%
24.6/100
1699
₹97754.71
26.5
Average
9.94%
Poor
14.54%
Average
0.2
Excellent
-8.07%
Poor
6.32%
Good
0.26%
83.4/100
2100
₹96022.50
17.4
Average
26.90%
Excellent
31.80%
Excellent
0.3
Excellent
34.39%
Excellent
13.02%
Good
0.72%
41/100
1145
₹95607.50
29.6
Average
11.75%
Average
14.80%
Average
0.2
Excellent
16.54%
Excellent
12.09%
Good
0.65%
61.5/100
2265
₹93544.50
45.8
Average
12.49%
Average
13.56%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%

Ambalal Sarabhai Enterprises Limited PE Ratio History

Historical price-to-earnings ratio for AMBALALSA — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.74₹53.5872.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Ambalal Sarabhai Enterprises Limited Quarterly Performance

Latest quarterly metrics for AMBALALSA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

1.05%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

13.44%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

4.35%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

9.51%

Compounded annual net profit growth over 5 years

Ambalal Sarabhai Enterprises Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for AMBALALSA — calculated from daily price history

27RSI 14
Oversold — RSI 27

Selling pressure is heavy — potential reversal zone.

SMA 50
39
▲ Price above SMA 50 — Short-term bullish
SMA 200
32
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
116K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Ambalal Sarabhai Enterprises Limited Financial Statements

Annual income statement, balance sheet and cash flow for Ambalal Sarabhai Enterprises Limited (AMBALALSA) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Ambalal Sarabhai Enterprises Limited

Loading latest quarterly results...

About AMBALALSA (Ambalal Sarabhai Enterprises Limited)

Ambalal Sarabhai Enterprises Ltd is a pioneer in the Indian pharmaceutical landscape, forging a legacy of innovation and commitment to healthcare solutions. Rooted in a rich histor...y, the company has evolved into a multifaceted organization dedicated to developing, producing, and distributing a diverse portfolio of pharmaceutical products. From addressing critical therapeutic areas like oncology and infertility to providing essential generic medications and animal health solutions, AMBALALSA strives to meet the evolving needs of patients and healthcare professionals. The company's emphasis on research and development ensures a steady pipeline of novel formulations and therapeutic advancements, solidifying its position as a trusted partner in promoting health and well-being. Driven by a pursuit of scientific excellence, AMBALALSA boasts state-of-the-art manufacturing facilities adhering to stringent global quality standards. This dedication to quality permeates every aspect of its operations, from sourcing raw materials to rigorous testing and packaging processes. The company's product range spans a wide spectrum, including specialized treatments for uro-gynaecological conditions, vital antifungal active ingredients, and vitamin C formulations. In addition to pharmaceuticals, AMBALALSA also offers analytical instruments and measuring tools, catering to the needs of research institutions and quality control laboratories. This holistic approach positions AMBALALSA as a comprehensive solution provider in the healthcare ecosystem. Beyond its core pharmaceutical offerings, AMBALALSA demonstrates a commitment to global reach, actively exporting its products to international markets. This strategic expansion reflects the company's ambition to improve access to quality healthcare worldwide. AMBALALSA also supports the pharmaceutical industry by supplying finished dosage forms and active pharmaceutical ingredients to other manufacturers. As it navigates the complexities of the modern healthcare landscape, AMBALALSA remains steadfast in its mission to enhance patient outcomes through innovative products, uncompromising quality, and a dedication to ethical practices, thereby solidifying its position as a significant contributor to the advancement of pharmaceutical science and patient care.

Company Details

Symbol:AMBALALSA
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Kartikeya Vikram Sarabhai M.A.
Executive Chairman & Whole Time Director
Mr. Mohal Kartikeya Sarabhai
MD & Director
Mr. Jinal Jaykumar Shah
Chief Financial Officer

AMBALALSA Share Price: Frequently Asked Questions

What is the current share price of Ambalal Sarabhai Enterprises Limited?

Ambalal Sarabhai Enterprises Limited (AMBALALSA) trades at ₹39.82 on NSE and BSE. Market cap ₹237.80 (Cr). Educational data only.

What is the P/E ratio of Ambalal Sarabhai Enterprises Limited?

Ambalal Sarabhai Enterprises Limited has a P/E of 12.88x vs industry average 34.89x.

What is the Bull Run score for Ambalal Sarabhai Enterprises Limited?

Ambalal Sarabhai Enterprises Limited has a Bull Run score of 29.1/100 based on 25+ financial parameters.

Does Ambalal Sarabhai Enterprises Limited pay dividends?

Ambalal Sarabhai Enterprises Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Ambalal Sarabhai Enterprises Limited?

Ambalal Sarabhai Enterprises Limited has ROE of 12.38%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Ambalal Sarabhai Enterprises Limited?

Ambalal Sarabhai Enterprises Limited has debt-to-equity of 0.36.

Is Ambalal Sarabhai Enterprises Limited a good investment?

Bull Run gives Ambalal Sarabhai Enterprises Limited a score of 29.1/100. This is not investment advice — consult a SEBI-registered advisor.